Fibrosis, a characteristic of all chronic kidney diseases (CKD), is now recognized to be an independent predictor of disease progression. Renal fibrosis is a complex process characterized by excessive ...

Kidney stones are a pain to deal with, literally and figuratively. But according to an expert, eating this common fruit can ...

Papillary – It is characterized by finger-like projections extending into ducts of the kidney. · Chromophobe – These are the cells that have a distinct light-staining cytoplasm. Sarcomatoid RCC though ...

and others such as succinate dehydrogenase-deficient RCC (SDH-RCC), hybrid oncocytic/chromophobe renal tumors (HOCTs), and oncocytic papillary renal neoplasm with reverse polarity. Recent studies have ...

Researchers have developed a new method that could be a significant step in the treatment of chronic kidney disease. The method can predict the progression of the disease, which could ensure better ...

Read about a cutting-edge study highlighting the impact of high pulse pressure on kidney outcomes in patients with ...

A team developed a human iPS cell-derived kidney organoid-based proximal tubule-on-chip -- OPTECs-on-Chip -- that mimics in vivo renal physiology more closely than ever before. This model exhibits ...

A phase 2 trial of ipilimumab plus nivolumab has met its primary end point of 12-month overall survival rate in non-clear ...

Roberto Pili, MD, associate dean for cancer research and integrative oncology at the Jacobs School of Medicine and Biomedical Sciences, is the principal investigator on a new five-year, $1.8 million ...

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase I for T-Cell Lymphomas.

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Metastatic Uveal Melanoma.